Targeted probiotic therapy in irritable bowel syndrome: a clinical evaluation on Clostridium butyricum CBM588 and Bifidobacterium longum W11

BackgroundIrritable Bowel Syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by symptoms such as abdominal pain, bloating, and altered bowel habits. Probiotic-based strategies are increasingly being explored for IBS management, with growing interest in strain-specific app...

Full description

Bibliographic Details
Published in:	Frontiers in Medicine
Main Authors:	Alexander Bertuccioli, Davide Sisti, Nadia Lazzerini, Chiara Maria Palazzi, Giordano Bruno Zonzini, Mirko Ragazzini, Annalisa Belli
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Subjects:	irritable bowel syndrome Clostridium butyricum CBM588 Bifidobacterium longum W11 probiotics IBS-D IBS-C
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1604319/full

Similar Items

<i>Clostridium butyricum</i> Strain MIYAIRI 588 (CBM588) as a Precision Probiotic Therapy in the Ketogenic Diet: A Possible Application?
by: Alexander Bertuccioli, et al.
Published: (2023-04-01)

Irritable Bowel Syndrome with Diarrhea (IBS-D): Effects of <i>Clostridium butyricum</i> CBM588 Probiotic on Gastrointestinal Symptoms, Quality of Life, and Gut Microbiota in a Prospective Real-Life Interventional Study
by: Francesco Di Pierro, et al.
Published: (2025-05-01)

Prognostic Impact of Clostridium butyricum MIYAIRI (CBM588) in Combination With Pembrolizumab for Advanced Urothelial Carcinoma: A Retrospective Cohort Study
by: Junya Arima, et al.
Published: (2025-08-01)

Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors
by: Yusuke Tomita, et al.
Published: (2022-12-01)

Sports-Related Gastrointestinal Disorders: From the Microbiota to the Possible Role of Nutraceuticals, a Narrative Analysis
by: Alexander Bertuccioli, et al.
Published: (2024-04-01)

A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live Bifidobacterium longum CECT 7347 (ES1) and heat-treated Bifidobacterium longum CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome
by: S Srivastava, et al.
Published: (2024-12-01)

The effect of probiotic (Clostridium butyricum) on adult patients with atopic dermatitis: a retrospective cohort study from TriNetX
by: Kuo-Hsiung Shu, et al.
Published: (2025-09-01)

Long-term probiotic administration for irritable bowel syndrome: a legal need
by: Olga I. Solovyeva, et al.
Published: (2023-10-01)

Association of probiotic use with nivolumab effectiveness against various cancers: A multicenter retrospective cohort study
by: Junya Arai, et al.
Published: (2023-08-01)

Probiotic Characteristics of Human-Residential Bifidobacterium longum subsp. longum Strains
by: WANG Mingfang, CHEN Lilan, ZHANG Xueling, TIAN Fengwei, NI Yongqing
Published: (2024-01-01)

The Role of Short-Chain Fatty Acids, Particularly Butyrate, in Oncological Immunotherapy with Checkpoint Inhibitors: The Effectiveness of Complementary Treatment with <i>Clostridium butyricum</i> 588
by: Massimiliano Cazzaniga, et al.
Published: (2024-06-01)

Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond
by: Susan Mills, et al.
Published: (2023-12-01)

Effect of physical activity on the severity of irritable bowel syndrome (IBS) symptoms
by: Ewelina Machała-Ćwikła, et al.
Published: (2024-07-01)

Multi-omics analyses the effect of Bifidobacterium longum subsp. longum BL21 supplementation on overweight and obese subjects: a randomized, double-blind, placebo-controlled study
by: Xiaoya Wang, et al.
Published: (2025-07-01)

Unique strain of Bifidobacterium longum and its efficacy in irritable bowel syndrome
by: E. Yu. Plotnikova
Published: (2021-01-01)

Assessing the post-treatment therapeutic effect of tongxie in irritable bowel syndrome: A randomized controlled trial
by: Yaoliang Lai, et al.
Published: (2022-09-01)

Effects of <i>Bifidobacterium longum longum</i> 35624® on the Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: Results of the Multicenter Observational Program SAGA
by: V. T. Ivashkin, et al.
Published: (2024-12-01)

Selection and in vitro Probiotic Properties of Bifidobacterium longum subsp. longum with Anti-diabetic Activity from the Intestinal Tract of Chinese Tajik Children
by: LI Si, AN Meiling, LI Longlong, ZHANG Ruirui, SUN Hailong, NI Yongqing
Published: (2025-05-01)

Differentiation of Bifidobacterium longum subspecies longum and infantis by quantitative PCR using functional gene targets
by: Blair Lawley, et al.
Published: (2017-05-01)

Rapid discrimination of Bifidobacterium longum subspecies based on MALDI-TOF MS and machine learning
by: Kexin Liu, et al.
Published: (2023-12-01)

Bifidobacterium longum Administration Diminishes Parasitemia and Inflammation During Plasmodium berghei Infection in Mice
by: Fitri LE, et al.
Published: (2023-03-01)

Comparative Genomic Analysis of Novel <i>Bifidobacterium longum</i> subsp. <i>longum</i> Strains Reveals Functional Divergence in the Human Gut Microbiota
by: Romina Díaz, et al.
Published: (2021-09-01)

Beyond IbMYB1: Identification and Characterization of Two Additional Anthocyanin MYB Activators, IbMYB2 and IbMYB3, in Sweetpotato
by: Jian Wang, et al.
Published: (2025-09-01)

Irritable bowel syndrome: systematic review of origin, pathology, diagnosis and treatment
by: Kacper Kwiliński, et al.
Published: (2024-08-01)

Yeast One-Hybrid Screening to Identify Transcription Factors for <i>IbMYB1-4</i> in the Purple-Fleshed Sweet Potato (<i>Ipomoea batatas</i> [L.] Lam.)
by: Danwen Fu, et al.
Published: (2023-07-01)

Exploring the therapeutic potential of Bifidobacterium longum subsp. longum CCFM1029 in Parkinson's disease: Insights from behavioral, neurophysiological, gut microbiota, and microbial metabolites analysis
by: Tiantian Li, et al.
Published: (2024-10-01)

Overexpression of the Golden SNP-Carrying <i>Orange</i> Gene Enhances Carotenoid Accumulation and Heat Stress Tolerance in Sweetpotato Plants
by: So-Eun Kim, et al.
Published: (2021-01-01)

Antioxidant effects of Bifidobacterium longum T37a in mice weight loss and aging model induced by D-galactose
by: Ya Wang, et al.
Published: (2023-04-01)

Quantitative Detection of <i>Bifidobacterium longum</i> Strains in Feces Using Strain-Specific Primers
by: Yue Xiao, et al.
Published: (2021-05-01)

Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut–brain–ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection
by: Yao Dong, et al.
Published: (2025-02-01)

Efficient Phytase Secretion and Phytate Degradation by Recombinant Bifidobacterium longum JCM 1217
by: Zhongke Sun, et al.
Published: (2019-04-01)

Academician of the Russian Academy of Sciences USHAKOV Igor Borisovich. On the 70th anniversary of his birth
Published: (2025-01-01)

Search for Super-Deformed Identical Bands in the <i>A</i> = 190 Mass Region on the Basis of Level Spin
by: Poonam Jain, et al.
Published: (2023-08-01)

Structural Analysis and Antioxidant and Immunoregulatory Activities of an Exopolysaccharide Isolated from <i>Bifidobacterium longum</i> subsp. <i>longum</i> XZ01
by: Xingyuan Zhang, et al.
Published: (2023-11-01)

Effectiveness of Bifidobacterium longum 35624 in the treatment of patients with irritable bowel syndrome: a systematic review
by: D. Andreev, et al.
Published: (2024-06-01)

Bifidobacterium longum suppresses colorectal cancer through the modulation of intestinal microbes and immune function
by: Fangjian Shang, et al.
Published: (2024-03-01)

Gut Dysbiosis in Irritable Bowel Syndrome: A Narrative Review on Correlation with Disease Subtypes and Novel Therapeutic Implications
by: Maria Napolitano, et al.
Published: (2023-09-01)

Bifidobacterium longum-Derived Extracellular Vesicles Prevent Hepatocellular Carcinoma by Modulating the TGF-β1/Smad Signaling in Mice
by: Bin Li, et al.
Published: (2024-06-01)

A Novel <i>Bifidobacterium longum</i> Subsp. <i>longum</i> T1 Strain from Cow’s Milk: Homeostatic and Antibacterial Activity against ESBL-Producing <i>Escherichia coli</i>
by: Andrey V. Machulin, et al.
Published: (2024-09-01)

Impact of Bifidobacterium longum NSP001 on DSS-induced colitis in conventional and humanised mice
by: Menglin Chen, et al.
Published: (2023-07-01)